A group of scientists from Instituto Gulbenkian de Ciência (IGC), led by Luís Moita, discovered that a hormone that has been pointed out as a treatment for obesity reduces the resistance to infection caused by bacteria and is a risk factor for sepsis. The work developed in collaboration with researchers from France, Germany and South Korea was recently published in the scientific journal Proceedings of the National Academy of Sciences USA.

Check the latest news in the press about this initiative (in Portuguese):

in RTP (interview for Bom Dia Portugal) 

in Público

in Visão

in SIC Notícias

in RTP